The current status of the clinical use of polysulphated glycosaminoglycan in the USA

Journal of Equine Veterinary Science

Volumn 16, Issue 2, 1996, Pages 53-57

  Jones, E Wynn ^a   White, G ^b  

^a MISSISSIPPI STATE UNIVERSITY   (United States)

^b Sallisaw Equine Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030557506     PISSN: 07370806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0737-0806(96)80155-9     Document Type: Review

References (49)

1. NADA No. 136-383: Freedom of Information Summary. US Food and Drug Administration.
2. Hamm D, Goldman L, Jones EW: Polysulfated glycosaminoglycan: a new intraarticular treatment for equine lameness. Veterinary Medicine June, 1984; 811.
3. Panse P, Jakab G, Barnabas K, et al.: Pharmacokinetic Studies on Intraarticularly Injected Glycosaminoglycan polysulfatre (GAGPS, Arteparon®) in Rabbits and in Man. Poster Presentation XIIth European Congress of Rheumatology, 30th June-6th July, 1991, Budapest, Hungary.
4. Muller W, Panse P, Brand S, Staubli A: In vivo study of the distribution, affinity to cartilage and metabolism of glycosaminoglycan polysulfate. Z Rheumatol 1983;42:355-361.
5. Jikuya K, Doi R: Studies on the absorption, distribution, excretion and metabolism of mucopolysaccharide polysulfate in animals. Shikoku Acta Medica 1975;31:1,99-110.
6. Muller W, Dick W, Panse P: Concentrations of glycosaminoglycan polysulfate in serum, in the synovia and in cartilage following intramuscular injection in humans Therapiewoche 1981;31:5902-5914.
7. Hamm D: Pers. Comm. 1994.
8. Gustafson SB, McIlwraith CW, Jones RL, et al.: Further investigations into the potentiation of infection by intraarticular injection of polysulfated glycosaminoglycan and the effect of filtration and intra-articular injection of amikacin. Am J Vet Res 1989; 50:2018-2022.
9. Nixon AJ: Intra-articular medication. In: Current Therapy in Equine Medicine 3. Robinson NE, (Ed.) 1992;127-131.
10. Hamm D, Jones EW: Intra-articular (IA) and intramuscular (IM) treatment of noninfectious equine arthritis (DJD) with polysulfated glycosaminoglycan (PSGAG). J Eq Vet Sci 1988;8:456-459.
11. NADA No. 140-901. Freedom of Information Summary. US Food and Drug Administration.
12. Rejholic V: Long-Term Studies of Osteoarthritis Drugs: An Assessment. Seminars in Arthritis and Rheumatism 1987;17(2,S1):35-53.
13. Collier MA, Haugland LM, DeBault LE, et al.: 3H-PSGAG concentrations in synovial fluid of equine coffin joints following a 500 mg intramuscular injection. Proc 39th Conv Am Assoc Equine Pract 1993;217-220.
14. Panse P, Zeiller P, Sensch KH: Distribution and excretion of a glycosaminoglycan polysulfate in rabbits after parenteral administration. Arzneim-Forsch (Drug Res) 1976;26:2024-2029.
15. Hamm J: Re-examination of NADA No. 140-901. Source data unpublished.
16. Caron JP, Kanlene JB, Miller R: Reported use and perceived efficacy of polysulfated glycosaminoglycan: A survey of the AAEP. Proc of the 40th Annual Convention Am Assoc of Eq Pract 1994;137-138.
17. 2 synthesis in Chinese hamster ovary cell cultures. Pharm Res Commun 1983;15:709-717.
18. Tsabori I, Matsuura T, Shichijo S, Yokayama M: Effects of glycosaminoglycan polysulfate on human neutrophil function. Jap J Inflamm 1988;8(2):131-135.
19. Rashmir-Raven AM, Coyne CP, Fenwick BW, et. al. Inhibition of equine complement activity by polysulfated glycosaminoglycan. Am J Vet Res 1992;53:37-90.
20. Todhunter RJ, Lust G: Polysulfated glycosaminoglycan in the treatment of osteoarthritis. JAVMA 1994;204(8):1245-1251.
21. Platt D, Bayliss MT: Proteoglycan metabolism of equine cartilage and its modulation by insulin-like growth factors. J Vet Pharmacol Therap 1995;18:141-149.
22. Fosang AJ, Tyler JA, Hardingham TE: Effect of interleukin-I and insulin-like growth factor-I on the release of proteoglycan components and hyaluronan from pig articular cartilage in explant culture. Matrix 1991;11:17-24.
23. Chunekamrai S, Krook LP, Lust G, Maylin GA: Changes in articular cartilage after intraarticular injections of methylprednisolone acetate in horses. Am J Vet Res 1989;50:1733-1741.
24. Wilhelmi G, Majer R: Experimental studies on the effects of drugs on cartilage. In: Articular Cartilage and Osteoarthrosis, Bern, Switzerland: Hansiber Publications, 1983:42-64.
25. McIlwraith CW: Traumatic arthritis and its treatment in the athletic horse. Equine Athlete 1989;2(1):1-6.
26. Rorvik AM, Grondahl AM: Markers of osteoarthritis: Review of the literature. Vet Surg 1995;24;3:255-262.
27. Jones EW, Hamm D: Clinical Pharmacology of Nonsteroidal Antiinflammatory Drugs. Proc 2nd Equine Pharmacology Symposium, Oct. 1978.
28. Baxter GM: Traumatic synovitis in the performance horse and its contribution to osteoarthritis. Equine Athlete 1992;5(1):18-23.
29. Clark DM: Current concepts in the treatment of degenerative joint disease. Compendium (N Am Ed), 1991;13(9):1439-1446.
30. Ghosh P: Osteoarthritis and hyaluronan. Seminars in Arthritis and Rheumatism 1993;22(8S1):1-3.
31. White G, Hamm D: Pers Comm 1994.
32. Ghosh P, Read R, Numata Y, et al.: The effects of intraarticular administration of hyaluronan in sheep. II. Cartilage Composition and Proteoglycan Metabolism. Seminars in Arthritis and Rheumatism 1993;22(6S1):31-432.
33. Hope N, Ghosh P, Thomas KF, et al.: Effects of intraarticular hyaluronan on matrix changes induced in lateral meniscus by total medial meniscectomy and exercise. Seminars in Arthritis and Rheumatism 1993;22(6S1):43-51.
34. Todhunter RJ, Altman NS, Kallfelz FA, et al.: Use of scintimetry to assess effects of exercise and polysulfated glycosaminoglycan on equine carpal joints with osteochondral defects. Am J Vet Res 1993; 54(7):997-1006.
35. Nelson D: Luitpold Pharmaceuticals Inc. Pers Comm 1994.
36. Fubini SL, Boatright CE, Todhunter RJ, et al.: Effect of intramuscularly administered polysulfated glycosaminoglycan on articular cartilage of equine joints injected with methylprednisolone acetate. Am J Vet Res 1993;54:1359-1365.
37. Kongtawelert P, Brooks PM, Ghosh P: Pentosan polysulfate (Cartrophen®) prevents the hydrocortisone induced loss of hyaluronic acid and proteoglycans from cartilage of rabbit joints as well as normalizes the keratan sulfate levels in serum. Rheumatol 1989;16:1454-1459.
38. Annefield M, Erne B, Rasser Y: Ultrastructural analysis of rat articular cartilage following treatment with dexamethosone and glycosaminoglycan-peptide complex. Clin Exp Rheum 1990;8:151-157.
39. Brennan JJ, Aherne FX, Nakano T: Effects of glycosaminoglycan polysulfate treatment on soundness, hyaluronic acid content of synovial fluid and proteoglycan aggregate in articular cartilage of lame bears. Can J Vet Res 1987;51:394-398.
40. McIlwraith W: Pers Comm 1993.
41. Crisman MV, Furr MO, Ley WB, et al.: Evaluation of polysulfated glycosaminoglycan for the treatment of navicular disease. A double blind study. Proc 39th Ann Conv of the AAEP 1993;219-220.
42. Altman RD, Dean DD, Muniz OE, et al.: Prophylactic treatment of canine osteoarthritis with glycosaminoglycan polysulfuric acid ester. Arthritis Rheum 1989;32:759-766.
43. Lust G, Williams AJ, Burton-Wurster N, et al.: Effects of intramuscular administration of glycosaminoglycan polysulfates on signs of incipienthip dysplasia in growing pups. Am J Vet Res 1992;53:1836-1843.
44. Goodship AE, Silver IA, Wilson AM: Treatment of tendonitis in horses. Vet Rec Jan 18, 1992.
45. Redding WR, Booth LE, Pool RR: The effects of polysulphated glycosaminoglycan on the healing of collagenase induced tendonitis of the equine superficial digital flexor tendon. Am J Vet Res (in press).
46. Glade MJ: Polysulfated glycosaminoglycan accelerates net synthesis of glycosaminoglycans by arthritic equine cartilage tissues and chondrocytes. Am J Vet Res 1990;51(5):779-785.
47. Miller W: Use of polysulfated glycosaminoglycan in treatment of indolent corneal ulcers of dogs. A clinical pilot study. In press, Vet Med 1995.
48. Salonen EM, Tervo T, Torma E, et al.: Plasmin in tear fluid of patients with corneal ulcers: Basis for new therapy. Acta Ophthalmologica 1987;65:3-12.
49. Burkhardt D, Ghosh P: Laboratory evaluation of antiarthritic drugs as potential chondroprotective agents. Seminars in Arthritis and Rheumatism 1987;17:3-34.